Literature DB >> 12792703

Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.

M M Deguti1, A M Sipahi, L C C Gayotto, S A Palácios, P L Bittencourt, A C Goldberg, A A Laudanna, F J Carrilho, E L R Cançado.   

Abstract

The hypothesis of the role of iron overload associated with HFE gene mutations in the pathogenesis of nonalcoholic steatohepatitis (NASH) has been raised in recent years. In the present study, biochemical and histopathological evidence of iron overload and HFE mutations was investigated in NASH patients. Thirty-two NASH patients, 19 females (59%), average 49.2 years, 72% Caucasians, 12% Mulattoes and 12% Asians, were submitted to serum aminotransferase and iron profile determinations. Liver biopsies were analyzed for necroinflammatory activity, architectural damage and iron deposition. In 31 of the patients, C282Y and H63D mutations were tested by PCR-RFLP. Alanine aminotransferase levels were increased in 30 patients, 2.42 1.12 times the upper normal limit on average. Serum iron concentration, transferrin saturation and ferritin averages were 99.4 31.3 g/dl, 33.1 12.7% and 219.8 163.8 g/dl, respectively, corresponding to normal values in 93.5, 68.7 and 78.1% of the patients. Hepatic siderosis was observed in three patients and was not associated with architectural damage (P = 0.53) or with necroinflammatory activity (P = 0.27). The allelic frequencies (N = 31) found were 1.6 and 14.1% for C282Y and H63D, respectively, which were compatible with those described for the local population. In conclusion, no evidence of an association of hepatic iron overload and HFE mutations with NASH was found. Brazilian NASH patients comprise a heterogeneous group with many associated conditions such as hyperinsulinism, environmental hepatotoxin exposure and drugs, but not hepatic iron overload, and their disease susceptibility could be related to genetic and environmental features other than HFE mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792703     DOI: 10.1590/s0100-879x2003000600009

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Authors:  James E Nelson; Elizabeth M Brunt; Kris V Kowdley
Journal:  Hepatology       Date:  2012-09-20       Impact factor: 17.425

Review 2.  Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ruben Hernaez; Edwina Yeung; Jeanne M Clark; Kris V Kowdley; Frederick L Brancati; Wen Hong Linda Kao
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

Review 3.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 4.  Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.

Authors:  Umbreen Ahmed; Patricia S Latham; Phillip S Oates
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

Review 5.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

6.  Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.

Authors:  Masato Yoneda; Yuichi Nozaki; Hiroki Endo; Hironori Mawatari; Hiroshi Iida; Koji Fujita; Kyoko Yoneda; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Shiro Maeyama; Kikuko Hotta; Atsushi Nakajima
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

7.  Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.

Authors:  Donald J Messner; Byung Han Rhieu; Kris V Kowdley
Journal:  Dig Dis Sci       Date:  2013-04-05       Impact factor: 3.199

8.  Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.

Authors:  Kayleigh L Wood; Michael H Miller; John F Dillon
Journal:  BMJ Open Gastroenterol       Date:  2015-02-17

9.  Serum Markers of Iron Metabolism in Chronic Liver Diseases.

Authors:  Mariana Penkova Radicheva; Albena Nikolaeva Andonova; Hristina Tancheva Milcheva; Nadejda Gospodinova Ivanova; Silviya Georgieva Kyuchukova; Mima Stefanova Nikolova; Agdalena Stefanova Platikanova
Journal:  Open Access Maced J Med Sci       Date:  2018-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.